Genetic and microbial determinants of azoxymethane-induced colorectal tumor susceptibility in Collaborative Cross mice and their implication in human cancer.
Dan LiChenhan ZhongMengyuan YangLi HeHang ChangNing ZhuSusan E CelnikerDavid W ThreadgillAntoine M SnijdersJian-Hua MaoYing YuanPublished in: Gut microbes (2024)
The insights into interactions between host genetics and gut microbiome (GM) in colorectal tumor susceptibility (CTS) remains lacking. We used Collaborative Cross mouse population model to identify genetic and microbial determinants of Azoxymethane-induced CTS. We identified 4417 CTS-associated single nucleotide polymorphisms (SNPs) containing 334 genes that were transcriptionally altered in human colorectal cancers (CRCs) and consistently clustered independent human CRC cohorts into two subgroups with different prognosis. We discovered a set of genera in early-life associated with CTS and defined a 16-genus signature that accurately predicted CTS, the majority of which were correlated with human CRCs. We identified 547 SNPs associated with abundances of these genera. Mediation analysis revealed GM as mediators partially exerting the effect of SNP UNC3869242 within Duox2 on CTS. Intestine cell-specific depletion of Duox2 altered GM composition and contribution of Duox2 depletion to CTS was significantly influenced by GM. Our findings provide potential novel targets for personalized CRC prevention and treatment.
Keyphrases
- endothelial cells
- genome wide
- high glucose
- induced pluripotent stem cells
- pluripotent stem cells
- early life
- dna methylation
- squamous cell carcinoma
- mesenchymal stem cells
- transcription factor
- quality improvement
- drug induced
- depressive symptoms
- social support
- cell therapy
- copy number
- replacement therapy
- lymph node metastasis
- childhood cancer